Carmell Corporation (CTCX)

Carmell Corporation Announces Completion of Post-Merger Integration with Axolotl Biologix and New Organizational Structure Aligned with Focus on Aesthetics

PITTSBURGH, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Carmell Corporation (Nasdaq: CTCX) (“Carmell”), a regenerative care company, today announced the completion of post-merger integration with Flagstaff-based Axolotl Biologix, a profitable regenerative medicine company (“Axolotl”). As part of the post-merger planning process, Carmell announced the following changes effective September 1, 2023: Rajiv Shukla, Executive Chairman of Carmell to serve as Chairman & CEO of Carmell.Randy Hubbell to step down